646 results

• After Recalling Oxbryta, Pfizer Seeks Dismissal of Class Action Brought by Former Users

  March 7, 2025

  Irvin Jackson

  Pfizer attorneys are seeking to have an Oxbryta class action lawsuit dismissed before they have to face plaintiffs before juries.

• FDA Removes Heart Attack, Stroke Warnings From Testosterone Drug Labels

  March 4, 2025

  Irvin Jackson

  Federal regulators are removing heart attack and stroke warnings from testosterone treatments following new studies that failed to find heart risks.

• Oxbryta Injury Lawsuit Over Discontinued Sickle Cell Disease Drug Set for Trial in June 2027

  February 28, 2025

  Irvin Jackson

  A federal judge has scheduled an Oxbryta lawsuit to go before a jury on June 7, 2027, which may be the first trial over side effects of the discontinued sickle cell disease drug.

• Ultra-Processed Foods Linked to 40% of Heart Disease Cases, Canadian Study Warns

  February 27, 2025

  Irvin Jackson

  A new Canadian study reveals that nearly 40% of all cases of heart disease and strokes in that country are linked to the consumption of ultra-processed foods.

• Uloric Removed From Market Following Years of Concerns About Potential Health Risks

  January 27, 2025

  Irvin Jackson

  The FDA and Takeda have announced that Uloric is being discontinued, due to heart risks and stiff competition from cheaper generic versions of the gout medication.

• Traffic Emissions Account for 70% of External Matter Found in Urbanites’ Lungs: Study

  January 13, 2025

  Martha Garcia

  A new study finds that traffic emissions could be responsible for as much as 70% of the air pollution deposited in the lungs in large urban areas, like Los Angeles, which could lead to respiratory problems, heart attacks and strokes.

• Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024

  December 30, 2024

  Irvin Jackson

  Former users of the recalled sickle cell disease drug Oxbryta have filed a class action lawsuit, claiming the manufacturer failed to warn consumers about risks associated with the medication, which can result in stroke and death.

• Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms

  November 19, 2024

  Irvin Jackson

  Illinois man has filed an Oxbryta lawsuit, indicating that the recalled sickle cell disease treatment caused a stroke shortly before Pfizer pulled the drug from the market.

• Side Effects of Beta Blockers May Increase Risk of Stroke After Surgery: Study

  November 11, 2024

  Martha Garcia

  Study finds that beta blockers may increase the risk of stroke after surgery, leading to calls for further research to determine how the medications can be safely used before medical procedures.

• Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years

  November 8, 2024

  Russell Maas

  Although hundreds of Oxbryta fatalities were reported through the FDA's adverse event reporting system, lawsuits point out that it took Pfiizer years to issue an Oxbryta recall.